2012, Number 3
<< Back Next >>
Acta Med Cent 2012; 6 (3)
Diagnostic methodology to reduce the cytomorphologic differential diagnosis of lymphoid neoplasms of predominant small cells
Faurés VLS
Language: Spanish
References: 15
Page:
PDF size: 48.39 Kb.
ABSTRACT
A diagnostic interpretative and integrative methodology for small cell lymphomas was designed and implemented in order to consider a more accurate cytomorphologic differential diagnosis, which is further reduced by integrating differential clinical characteristics among each of the diseases defined by the World Health Organization classification of lymphoid neoplasms included in the differential diagnosis. A total of 28 cases were selected. They were diagnosed by fine needle aspiration biopsy with initial diagnostic difficulty or when the methodology was applied, and clinically suspected cases of lymphomas having no known primary tumor. The following criteria were taken into account for the application of the methodology: the cytomorphological similarities and differences, the size and the predominant cell type (or both), and other reactive cell types present in the tumor cell microenvironment. Three cytomorphologic patterns of predominant small cell were identified: small to medium cells with numerous mitosis, with occasional large cell, and mixed. The neoplastic lymphoid illnesses to be considered are reduced in the differential diagnosis, and this methodology is feasible to be implemented in departments with limited technical resources available.
REFERENCES
1.Arber J. Diagnostic algorithm for clonality molecular testing in lymphoid proliferations. J Mol Diagn. 2000; 2(4): 178–90.
2.Mathur S, Dawar R, Verma K. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology. Indian J Pathol Microbiol. 2007 jan; 50(1): 46-50.
3.Onofre ASC, Pomjanski N, Buckstegge B, Böcking A. Immunocytochemical Typing of Primary Tumors on Fine-Needle Aspiration Cytologies of Lymph Nodes. Diagn Cytopathol. 2008 apr; 36(4): 207-15.
4.Mathiot C, Decaudin D, Klijanienko J, Couturier J, Salomon A, Dumont J. Fine-Needle Aspiration Cytology Combined With Flow Cytometry Immunophenotyping: Is a Rapid and Accurate Approach for the Evaluation of Suspicious Superficial Lymphoid Lesions. Diagn Cytopathol. 2006 jul; 34(7): 472-8.
Dey P. Role of ancillary techniques in diagnosing and subclassifying non-Hodgkin’s lymphomas on fine needle aspiration cytology. Cytopathology. 2006 oct; 17(5): 275-87.
Rui L, Schmitz R, Ceribelli M, Staudt LM. Malignant Pirates of the Immune System. Nature Immunology. 2011; 12: 933–40.
7.Pathological Society of Great Britain and Ireland. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. London: John Wiley & Sons; 2010.
8.Gregory CD, Pound JD. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol. 2011 jan; 223(2): 177-94.
9.Zhang JR, Raza AS, Greaves TS, Cobb C. Fine-needle aspiration diagnosis of Hodgkin lymphoma using current WHO classification--re-evaluation of cases from 1999-2004 with new proposals. Diagn Cytopathol. 2006 jun; 34(6): 397-402.
10.Kolonic SO, Prasek-Kudrna K, Roso V, Radic-Kristo D, Planinc-Peraica A, Dzebro S, et al. Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience. Coll Antropol. 2010 mar; 34(1): 309-13.
11.Hamid GA, Hanbala N. Comparison of bone marrow aspiration and bone marrow biopsy in neoplastic diseases. Gulf J Oncolog. 2009 jul; (6): 41-4.
12.Caraway NP, Katz RL. Lymph Nodes. In: Koss LG, Melamed MR. Koss diagnostic cytologyand its histopathologic bases. Philadelphia: Lippincott; 2006. p. 1186-1228.
13.Xianfeng F. Zhao FX. Pitfalls in diagnostic hematopathology – Part II. Int J Clin Exp Pathol. 2010; 3(1): 40.
14.Alam K, Khan R, Jain A, Maheshwari V, Agrawal S, Chana RS, et al. The value of fineneedle aspiration cytology in the evaluation of pediatric head and neck tumors. Int J Pediatr Otorhinolaryngol. 2009; 73(7): 923-7.
15.Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009: 523-31.